GoldBamboo.com - Knowledge is strong medicine
  

VIVUS Announces Results Of ALISTA Phase 2b Study - News


  Not Signed In - Sign In / Register


Get Your Free Credit Report Right Now!

Zip Code:



General Topics A-Z

VIVUS Announces Results Of ALISTA Phase 2b Study

Sat, 30 Sep 2006 07:00 AM EST

... VIVUS, Inc. (Nasdaq: VVUS), today announced results of the company's Phase 2b clinical study of its investigational drug ALISTA(TM) (topical alprostadil), for the treatment of female sexual arousal disorder (FSAD), in women who have undergone a hysterectomy. [click link for full article] ...

Related Topics

Take control over your directory listings...INSTANTLY

Every day, thousands of users find businesses like yours in the GoldBamboo directory.

Limited Time Offer!!!

For only $30 a year, a savings of 70% off our standard rate:

  • Edit your listing (whenever you want!)
  • Link to your website
  • Choose which categories you are listed in
  • Describe your services

The process will take only a few minutes and consists of 3 easy steps:

1. Register     >     2. Edit Listings     >     3. Publish

Your Company
your street
yourtown, YS 12345
888-888-8888



No Thanks

GoldBambooTM

Your Integrative Health and Wellness Resource

November 22, 2009


Page Updated: January 17, 2009
============== Advertisement ==============
Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.

Home | About Us | Link To Us | Feedback | Disclaimer | Privacy Policy | Terms of Use | Health Forums

Copyright © 2004-2009 - Anaconda Partners LLC - All rights reserved.

HONcode accreditation seal.

We comply with the HONcode standard for health trust worthy information:
verify here.